Centene (NYSE:CNC) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says

Key Points

• Jefferies raised its price target to $48 (from $39) but kept a Hold rating; analysts' consensus remains a Hold with an average price target of about $49.76.
• Shares jumped 6.1% to $52.60 after a strong Q1 beat—adjusted EPS $3.37 vs. $2.12 and revenue $49.94B—and management raised 2026 guidance, citing improved medical-cost controls and Medicaid strength.
• Key risks include a reported ~2 million decline in ACA individual-market enrollment, ongoing commercial membership softness, and recent insider selling, which could temper the stock's momentum.

Centene (NYSE:CNC - Get Free Report) had its price objective lifted by research analysts at Jefferies Financial Group from $39.00 to $48.00 in a research report issued to clients and investors on Wednesday,MarketScreener reports. The firm currently has a "hold" rating on the stock. Jefferies Financial Group's price objective indicates a potential downside of 8.75% from the company's previous close.

A number of other equities analysts also recently issued reports on CNC. Robert W. Baird lifted their price target on Centene from $36.00 to $37.00 and gave the company a "neutral" rating in a research note on Wednesday, April 15th. UBS Group lifted their target price on Centene from $42.00 to $55.00 and gave the company a "neutral" rating in a research report on Wednesday. Morgan Stanley raised their price objective on Centene from $38.00 to $45.00 and gave the company an "equal weight" rating in a research note on Wednesday, March 4th. Mizuho set a $41.00 price target on shares of Centene and gave the stock a "neutral" rating in a report on Tuesday, March 10th. Finally, Wall Street Zen downgraded Centene from a "buy" rating to a "hold" rating in a research note on Sunday, February 15th. Six investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $49.76.

Centene Stock Up 6.1%

Shares of CNC stock traded up $3.03 on Wednesday, reaching $52.60. 2,817,833 shares of the company were exchanged, compared to its average volume of 6,445,257. The company has a 50-day moving average of $38.49 and a 200-day moving average of $39.24. Centene has a one year low of $25.08 and a one year high of $64.15. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.10. The company has a market cap of $25.87 billion, a price-to-earnings ratio of -3.89, a PEG ratio of 0.96 and a beta of 0.59.

Centene (NYSE:CNC - Get Free Report) last released its quarterly earnings data on Tuesday, April 28th. The company reported $3.37 EPS for the quarter, beating the consensus estimate of $2.12 by $1.25. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The firm had revenue of $49.94 billion during the quarter, compared to the consensus estimate of $47.58 billion. During the same quarter in the previous year, the company posted $2.90 earnings per share. The company's quarterly revenue was up 7.1% on a year-over-year basis. Analysts anticipate that Centene will post 3.01 earnings per share for the current year.

Institutional Trading of Centene

A number of institutional investors have recently modified their holdings of the business. DV Equities LLC bought a new position in Centene in the 4th quarter worth approximately $26,000. IFC & Insurance Marketing Inc. purchased a new stake in shares of Centene during the fourth quarter worth $28,000. Addison Advisors LLC grew its position in shares of Centene by 455.6% in the third quarter. Addison Advisors LLC now owns 739 shares of the company's stock valued at $26,000 after purchasing an additional 606 shares in the last quarter. SBI Securities Co. Ltd. lifted its holdings in Centene by 118.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 749 shares of the company's stock worth $31,000 after purchasing an additional 406 shares in the last quarter. Finally, Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of Centene during the third quarter valued at about $27,000. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Centene

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Q1 earnings beat and guidance lift — Centene reported adjusted EPS well above estimates ($3.37 vs. consensus ~ $2.12), revenue beat, and raised 2026 EPS guidance after improving medical-cost controls. This is the primary driver of the stock move. PR Newswire
• Positive Sentiment: Cost controls + Medicaid strength — Management cited declining medical costs and stronger Medicaid performance, improving margins and lifting investor confidence in near-term profitability. Reuters
• Positive Sentiment: Bank of America upgraded CNC to Buy with a $60 price target (from $34), backing the rebound story and providing further buy-side support. Benzinga
• Positive Sentiment: Unusual bullish options flow — Large purchases of call options (≈19,116 contracts) indicate short-term speculative/hedge positioning ahead of/after the print (possible short-covering or directional bets).
• Neutral Sentiment: Earnings-call tone mixed — The Q1 call showed strong results but a cautious management tone on outlook details and membership trends; watch commentary for FY cadence. TipRanks
• Neutral Sentiment: Mixed analyst landscape — Some upgrades and higher targets (e.g., BofA) but a wide range of price targets and recent sell/hold calls leave consensus still mixed; volatility in estimates likely. QuiverQuant
• Negative Sentiment: ACA (Obamacare) enrollment drop — Reports show a ~2 million decline in individual-market enrollment after subsidy changes, a structural headwind for Centene’s individual business going forward. Forbes
• Negative Sentiment: Commercial enrollment slide persists — While Medicaid helped, commercial membership softness remains a risk to revenue growth and could temper margin gains. Benzinga
• Negative Sentiment: Insider selling and large institutional rebalancing — Recent insider stock sales and big fund position turnover could keep selling pressure at times. QuiverQuant

Centene Company Profile

Centene Corporation NYSE: CNC is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children's Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene's offerings extend beyond traditional insurance to include a range of specialty and support services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.